Additional information
Brown semisolid
25670-17-1
ACI-031716
NA
C42H69ClN2O7S
781.52
Ambient
2 – 8°C, dark
Antibiotic
Pharmaceutical Impurity Standards
Methyl a-trans-7-chloro-6,7,8-trideoxy-3,4-O-(p-methoxybenzylidene)-6-(1-methyl-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-D-galacto-octopyranoside 2-Palmitate (Anisylidene clindamycin palmitate)
Methyl a-trans-7-chloro-6,7,8-trideoxy-3,4-O-(p-methoxybenzylidene)-6-(1-methyl-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-D-galacto-octopyranoside 2-Palmitate Monohydrochloride (Anisylidene clindamycin palmitate)
3,4-O-p-Anisylideneclindamycin Palmitate Hydrochloride





![N-ETHYL AZILSARTAN MEDOXOMIL (25 mg) ((5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-{[2′-(4-ethyl-5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-4-biphenylyl]methyl}-1H-benzimidazole-7-carboxylate)](https://analyticachemie.in/ver-2/wp-content/uploads/uspimage-1.jpg)